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SUMMARY 
A high-performance liquid chromatographic (HPLC) assay suitable for the evaluation of 
3-methoxy-4-hydroxyphenylglycol (MHPG) in l-ml aliquots of plasma is presented. 
Preparatory steps include extraction into ethyl acetate and minicolumn chromatography. 
Recoveries are monitored with L3H]MHPG. The HPLC procedure utilizes a C,, column, 
isocratic elution and amperometric detection. The assay was checked against a gas chromato- 
graphic-mass spectrometric procedure; the two procedures correlated well with a correla- 
tion coefficient of 0.99. Intra-assay reproducibility was 5.4%, inter-assay reproducibility 
10.7%. Immediate changes in the orthostatic position did not affect the plasma MHPG 
concentration. Based on 22 normal controls the daytime plasma MHPG level was 2.98 + 0.66 
ng/ml (mean t S.D.). 
INTRODUCTION 
The noradrenergic system has been implicated in a variety of psychiatric 
disorders. Much of this work has been on depression, but also psychoses 
have been studied, and anxiety disorders are a rapidly growing area of 
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interest. The obvious difficulties of directly assessing noradrenergic 
function in the intact brain have led to a variety of alternative strategies. 
Measurement of plasma or urinary catecholamines has been widely used, 
but plasma half-lives are only a few minutes, and levels are sensitive to 
posture, diet and emotional arousal [l-4]. The search for a more 
stable indicator of noradrenergic function led quickly to 3-methoxy-4- 
hydroxyphenylglycol (MHPG), the major metabolite of norepinephrine in 
cerebrospinal fluid (CSF) [ 51. The demonstration that cerebral venous blood 
has higher levels of MHPG than arterial blood supports the use of MHPG as an 
indicator of central noradrenergic activity [6]. Elsworth et al. [‘7] have shown 
that plasma MHPG levels in vervet monkeys are highly correlated (r = 
0.94- 0.99) with brain MHPG directly measured in a variety of areas, thus 
validating much of the research that has been done on and the conclusions 
drawn from MHPG measurements. 
Recent studies have revealed a complex picture of MHPG transport and 
metabolism [8] . It is water-soluble, and it should not therefore be surprising 
that it is transported to the CSF from the periphery as well as vice versa. A 
two-compartment model has been used to describe the system [9] . Previous 
estimates of the proportion of plasma MHPG that originates in brain were 
elevated because it was not recognized that half of plasma MHPG is 
metabolized to vanilmandelic acid. Kopin et al. [9] suggest that less than 25% 
of plasma MHPG originates in brain. Despite these reconsiderations regarding 
the source of plasma MHPG, it remains the single most useful measure of 
sympathetic activity. 
The majority of psychiatric studies use a between-subjects design to identify 
differences between groups of patients and normals, and the stability of MHPG 
levels avoids much of the rapid individual variation that characterizes catechol 
amine measurements. The half-life of MHPG in plasma is approx. 30 min. 
Standing and mental stress do not influence plasma MHPG levels in periods 
shorter than 20 min [lo] , Acute administration of caffeine does not appear to 
change plasma MHPG levels [ 111 . 
In manic depressive patients, urinary MHPG levels are lower during depres- 
sion and higher during mania [12] . Urinary MHPG levels are reduced in 
patients with endogenous depression associated with bipolar disorders as 
compared to normals and to patients with non-endogenous depressions [13]. 
Low levels of urinary MHPG may predict response to imipramine treatment 
[ 141 . Long-term benzodiazepine treatment is associated with substantial 
reductions in urinary MHPG, which return toward normal during drug with- 
drawal [15]. Plasma free MHPG is highly correlated (r = 0.59) with self-ratings 
of state anxiety in normal subjects [ 161 . Plasma free MHPG increases in 
response to administration of an a,-adrenergic blocker, yohimbine, and these 
increases are higher in patients with anxiety disorders than in normals [1’7] . 
MHPG measurements offer an important tool for psychiatry, and accurate, 
fast and efficient methods to measure it are of obvious importance. However, 
simple reliable plasma or serum assays for MHPG are scarce. The method of 
choice for plasma MHPG has been a combination of gas chromatography mass 
spectrometry (GC--MS) [ 18, 191. A few high-performance liquid chromato- 
graphy (HPLC) assays for MHPG have been described for urine [20, 211 and 
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CSF [ 22, 231 , A few HPLC assays for plasma MHPG concentrations have been 
published [ 24---281 . We are describing an alternative, easily performed and 
reproducible HPLC procedure for plasma MHPG which boasts simple 




Tritiated MHPG was prepared in-house as described below. From Sigma (St. 
Louis, MO, U.S.A.) we obtained 3,4-dihydroxyphenylglycol, MHPG and 
Na,EDTA. A sample of 3-hydroxy-4-methoxyphenylglycol (iso-MHPG) was a 
generous gift from Dr. H.J. G&-tner (Eberhard-Karls-Universit& Tiibingen, 
F.R.G.). 
Catechol-O-methyl transferase (COMT) was prepared in-house from rat liver 
[29] . It has become available commercially as well (Upjohn, Kalamazoo, MI, 
U.S.A.). 
Tritiated S-adenosyl-L-methionine (g---l5 Ci/mol) was purchased from New 
England Nuclear (Boston, MA, U.S.A.). Tris buffer (500 mM) was made up to 
contain 150 mM magnesium chloride, 15 mM ethyleneglycoltetraacetic acid 
(EGTA) and 4.9 mM glutathione (all from Sigma) and 0.4 mM benzyloxyamine 
(Aldrich, Milwaukee, WI, U.S.A.). HPLC-grade ethyl acetate was used for 
various extractions. For preliminary separation of [“HI MHPG, Merck silica 
thin-layer chromatography (TLC) plates, 0.25 mm thickness, 20 X 20 cm 
(American Scientific Products, Romulus, MI, U.S.A.) were used. The TLC 
developing solution was propanol-2- ammonium hydroxide- water (16: 1: 3). 
Heparinized vacutainers or catecholamine collection tubes containing 6 mg 
glutathione and 9 mg EGTA per 5 ml blood [30] were used. 
Reagents for the extraction of MHPG from plasma included 0.9% sodium 
chloride solution, 0.1 M acetic acid and water-saturated ethyl acetate. 
A DuPont Type OD cartridge (DuPont, Wilmington, DE, U.S.A.) was used as 
a minicolumn in the preparatory steps. The pH 4.15 elution buffer for this 
step consisted of 89 mM sodium acetate containing 13.6% methanol. The 
HPLC step utilized a 30 cm X 3.9 mm PBondapak Cl8 column, 10 pm particle 
size (Waters Assoc., Milford, MA, U.S.A.), an LC-4A amperometric detector 
(BioAnalytical Systems, West Lafayette, IN, U.S.A.) and a pH 4.15 mobile 
phase consisting of 89 mM sodium acetate containing 4% methanol and 0.1 
mM EDTA. 
Methods 
Synthesis of radioactive MHPG to monitor recoveries. The synthesis of 
radioactive MHPG was based on, and analogous to, the 3-0-methylation 
step of the single isotope derivative assay for catecholamines [31]. 3,4-Di- 
hydroxyphenylglycol (1 pg), 0.4 ml Tris buffer, 0.1 ml COMT and 0.3 ml 
tritiated S-adenosyl-L-methionine were incubated for 2.5 h at 37°C. The 
reaction was stopped by addition of 0.1 ml of 0.1 M EDTA. MHPG, tritium- 
labeled in the 3-O-methyl position, as well as iso-MHPG, labeled in the 4-0- 
methyl position, were extracted with 3 X 4 ml water-saturated ethyl acetate. 
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The fractions were pooled and evaporated under nitrogen. The residue was 
reconstituted in 200 ~1 methanol, spotted on a silica TLC plate and developed 
in the TLC developing solution. The area where an authentic MHPG standard 
migrated was eluted with 2 X 3 ml methanol. 
The eluates were combined, evaporated and reconstituted in 200 ~1 mobile 
phase; 100 ~1 were injected onto the HPLC column under the assay conditions 
elaborated below. Fractions of 0.5 ml were collected and those eluting with 
authentic MHPG were pooled. A small aliquot of the pooled [3H] MHPG was 
reinjected onto the HPLC column and specific activity calculated from peak 
height and radioactivity. Iso-MHPG, which traveled with MHPG on the TLC 
system described here, was separated by the HPLC step. Labeled iso-MHPG 
could, therefore, be obtained from the same procedure by collecting the 
appropriate fraction(s) from the preparatory HPLC step. The labeled MHPG 
was stable for at least a year at -20°C. It could be repurified readily on an 
HPLC system, should the need arise. 
Extraction of plasma MHPG. To 1 ml plasma, 5000 cpm [ 3H] MHPG and 0.5 
ml of sodium chloride solution were added. The pH was adjusted to 5.0 with 
0.1 M acetic acid. The mixture was extracted on a multi-sample vortex (SMI, 
Emeryville, CA, U.S.A.) for 2 X 10 min, each time with 5 ml of water-saturated 
ethyl acetate. The two supernatants were pooled in a clean glass tube and 
evaporated under reduced pressure. The residue was reconstituted in 200 1.11 
of water and applied to a preparatory minicolumn which had been activated 
with 2 ml methanol followed by 2 ml mobile phase. The minicolumn was 
placed in the Prep I (DuPont De Nemours, Wilmington, DE, U.S.A.) which was 
used to wash with 0.25 ml mobile phase, then to elute the MHPG with 0.6 ml 
of elution buffer and finally to dry this eluate. The residue obtained from the 
Prep I was reconstituted in 200 1.11 mobile phase, 25 ~1 of which were counted 
in Bray’s solution to determine extraction recoveries and 100 ~1 of which were 
injected onto the HPLC column. 
HPLC conditions. Separation and quantitation of MHPG was achieved 
isocratically on a PBondapak Cl8 column with the mobile phase. A Model 110A 
Altex pump (Anspec, Ann Arbor, MI, U.S.A.) was used to adjust the flow-rat.e 
to 1 ml/min, and the column effluent was monitored with an amperometric 
detector equipped with a glassy carbon electrode. The electrochemical detector 
was set at +0.73 V applied potential and 1 nA range. While we used room 
temperature to run MHPG on the HPLC system, that room temperature should 
be controlled to range between 18 and 24°C. A five-point standard curve of 
MHPG in mobile phase was prepared daily by adding 2.5- 20 ng MHPG to l-ml 
aliquots of mobile phase. Aliquots of 100 1.11 of these solutions were injected 
directly onto the HPLC column. 
Collection of normal controls. Ten healthy volunteers (five men and five 
women), who had given written consent, were asked to lie supine. A butter- 
fly needle fitted with a heparin lock was inserted immediately into the anti- 
cubital vein and six blood samples of 7 ml each were drawn at lo-min intervals 
for 50 min. At that time the subjects were asked to stand for 15 min and a final 
blood specimen was drawn. From an additional twelve individuals (five men 
and seven women) blood samples were drawn seated using simple venipuncture. 
All samples were processed immediately and the plasma was frozen at - 20°C 
until analysis. 
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To check the accuracy of our assay eight plasma samples ranging from 2 to 
15 ng/ml were also analyzed by GC-MS, courtesy of Dr. David C. Jimerson 
(National Institute of Health, Mental Health Division, Bethesda, MD, U.S.A.). 
The samples were selected and MHPG was added to the last two to give a broad 
range of values for the comparison study. 
Inter-assay reproducibility was evaluated by inclusion of an individually 
frozen aliquot obtained from one of four plasma pools in each separate assay 
and of thirteen samples, each run in more than one assay. Each plasma pool 
was assayed in eight to nineteen separate assays. Intra-assay reproducibility was 
evaluated from the variation encountered between 22 duplicate samples 
assayed within specific runs, frequently at the beginning and end of a given run. 
Recovery of added MHPG was based on the standard curves generated from 
plasma to which known quantities of authentic MHPG ranging from 0.5 to 20 
ng/ml were added. 
RESULTS 
Methylation of 3,4-dihydroxyphenylglycol by [ 3H] S-adenosyl-L-methionine 
and COMT resulted in a mixture of compounds from which MHPG and iso- 
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Fig. 1. HPLC profile of the partially purified products derived from the COMT methylation 
of 3,4-dihydroxyphenylglycol with tritiated S-adenosyl-L-methionine. The solid line is the 
elution pattern as monitored with an amperometric detector and a glassy carbon electrode. 
The dotted line represents tritium counts obtained for the corresponding effluents. 
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the conditions used MHPG and iso-MHPG together with their tritiated 
analogues were isolated from the Cl8 column at 8 and 12 min, respectively (Fig. 
1). The specific activity of various [3H] MHPG preparations produced by this 
method in our laboratory was of the order of 7 yCi/nmol. 
Chromatograms obtained from the analytical HPLC assay of standards 
and plasma MHPG are shown in Fig. 2. The assay is linear for injections ranging 
from 0.25 to 2 ng per 100 ~1 or from 2.5 to 20 ng/ml. Recoveries of MHPG 
through the preparatory steps of the procedure, based on the recovery of radio- 
active tracer, range from 25 to 35%. The percentage recovery can be increased 
by increasing the amount of ethyl acetate used for extraction; however, at the 
time this paper was written we were interested in maintaining the lowest 
possible volume for the subsequent evaporation step. Using this radioactive 
tracer to correct for losses the overall assay recovery of MHPG, added in 
0.5-- 10 ng/ml concentrations to plasma, is 100 + 2.2% (mean i standard error 
of the mean, n = 21). 
0 10 0 10 10 0 10 0 10 0 10 
Fig. 2. HPLC profiles of (a) MHPG standards (0.25, 0.5, 1.0 and 2.0 ng), (b) buffer only and 
(c) plasma. 
Eight duplicate plasma samples ranging from 2 to 15 ng/ml assayed by Dr. 
David C. Jimerson utilizing GC-MS, gave a correlation of 0.99 with the HPLC 
procedure as shown in Table I. Even with the omission of the 14.7 ng/ml value, 
a correlation of 0.94 was obtained. Slope of the regression curve for the two 
methods is 0.90 indicating slightly, albeit not statistically significant, higher 
values by the HPLC procedure. 
The intra-assay coefficient of variation was 5.4% (IZ = 14), the inter-assay 
coefficient of variation 10.7% (n = 29). The limit of sensitivity of the assay was 
< 125 pg per injection or approx. 1.25 ng/ml of plasma. 
Unlike plasma norepinephrine, plasma MHPG is relatively independent of 
the posture which has been assumed for blood collection. Based on an 
univariate Anova analysis, samples drawn immediately and 10 min after 
subjects assumed the supine position (samples A and B, Table II) are not signif- 
icantly different in MHPG concentration than one drawn 50 min later (sample 
F, Table II). Plasma concentrations obtained after 15 min of standing (sample 
97 
TABLE I 
COMPARISON OF PLASMA MHPG LEVELS DETERMINED BY GC-MS AND HPLC 











IMMEDIATE EFFECT OF ORTHOSTATIC POSITION ON PLASMA MHPG 
CONCENTRATIONS 
Based on a univariate Anova analysis (MIDAS, University of Michigan MTS system) there is 
no significant difference between these plasma MHPG values. 
Sample Plasma MHPG concentration 
(mean * S.D., n = 10) 
(ndml) 
A. Immediately after lying down 3.02 + 0.70 
B. 10 min supine 2.71 + 0.67 
C. 20 min supine 2.48 + 0.51 
D. 30 min supine 2.61 + 0.48 
E. 40 min supine 2.80 i 0.34 
F. 50 min supine 2.60 ?; 0.67 
G. 15 min after standing up 2.85 t 1.16 
G, Table II) are no different than the final supine ones (sample F, Table II). 
The mean normal value for daytime plasma MHPG based on 22 healthy 
adults was 2.98 of: 0.66 ng/ml (mean 2 S.D.). No significant difference was 
evident between males and females in this limited population, nor was there an 
age-related difference discernable in this small group. 
DISCUSSION 
The assay for MHPG described here is based on a relatively simple procedure. 
‘The use of a radioactive.internal standard for the evaluation of MHPG recovery 
through the preparatory procedure was more satisfactory than the use of the 
traditional HPLC internal standard. Alternative internal standards which were 
considered included 3-hydroxybenzyl alcohol and iso-MHPG. Of the com- 
pounds tested, iso-MHPG appeared to be the most suitable; however, in a few 
plasma samples an interfering peak was noted on the HPLC profile, even with 
this compound. On the other hand, the use of tritium labeling allows accurate 
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corrections to be made for each individual sample for the substantial losses 
incurred in the preparatory steps. Subsequent errors owing to the HPLC 
procedure were negligible in our hands. The mass of MHPG added with the 
tritium label must be subtracted from the final answer. 
The DuPont Prep 1 with its OD cartridge works well for the clean-up and 
concentration of the sample prior to HPLC. The use of these reversed-phase 
minicolumns reduces the load of unwanted chemicals which are placed on the 
HPLC column substantially. This allows for the 12-min HPLC running time per 
sample. In laboratories which do not have the appropriate centrifuge available, 
minicolumns can be eluted rapidly using vacuum pump systems. 
The HPLC elution times, as with all other HPLC methods, are a function of 
the composition of the mobile phase, column packing, the age of the column 
and the temperature at which the column is eluted. The unidentified peak 
which normally elutes at lo- 11 min is much more sensitive to changes in 
temperature than MHPG. If the ambient temperature rises above 24.- 25”C, 
this peak will elute rapidly enough to interfere with the MHPG peak. The Cl8 
column used needs regular weekly rinsing with 100% methanol; however, given 
columns have been good for more than 650 injections in our hands. 
A standard curve is run daily since, although the electrochemical detector 
response to the MHPG is linearly proportional, the recorded peak height is not 
necessarily in a 1:l relationship to the concentration of MHPG, i.e. a plot of 
peak height versus MHPG concentration yields a straight line whose slope is 
not necessarily 1. 
The measure for MHPG is substantially more robust than that for norepi- 
nephrine or epinephrine. The physiological levels of MHPG change more slowly 
than those of their catecholamine precursors. From a purely chemical point of 
view MHPG is more stable than norepinephrine or epinephrine because the ring 
catechol groups have been stabilized by methylation of the 3-OH position and 
the glycol side-chain is less reactive than the amine one. In addition, the plasma 
MHPG concentrations are an order of magnitude higher than those of plasma 
norepinephrine and two orders of magnitude higher than those of plasma epi- 
nephrine. 
The evidence today suggests that there is an interaction or some sort of 
linkage between the brain adrenergic systems and the functioning of peripheral 
catecholamine neurons, particularly those of the sympathetic nervous system 
[32]. The assay of plasma MHPG may therefore be of considerable utility 
when there is a need to evaluate catecholamine status. 
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